Brickell Biotech Inc (NASDAQ:BBI)
| 0.0978 Delayed Data As of Jul 01 |  -0.0282 / -22.38%Today’s Change | 0.09 Today|||52-Week Range 0.96 | -57.27% Year-to-Date |
Latest BBI News | Press Releases
No recent news for Brickell Biotech Inc.
Today’s Trading
| Previous close | 0.13 |
| Today’s open | 0.13 |
| Day’s range | 0.09 - 0.15 |
| Volume | 1,282,426 |
| Average volume (3 months) | 7,057,812 |
| Market cap | $11.5M |
Data as of 4:03pm ET, 07/01/2022
Growth & Valuation
| Earnings growth (last year) | +42.39% |
| Earnings growth (this year) | +61.90% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -77.83% |
| P/E ratio | NM |
| Price/Sales | 45.51 |
| Price/Book | 0.46 |
Competitors
| ---- | ||
| PTIXProtagenic Therapeut... | -0.02 | -2.17% |
| BLPHBellerophon Therapeu... | -0.03 | -2.44% |
| NBRVNabriva Therapeutics... | +0.00 | +2.31% |
Data as of 3:59pm ET, 07/01/2022
Financials
| Next reporting date | August 17, 2022 |
| EPS forecast (this quarter) | -$0.03 |
| Annual revenue (last year) | $404.0K |
| Annual profit (last year) | -$39.5M |
| Net profit margin | -9,770.79% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Boulder, Colorado |
Forecasts
